MB;BS · FWACS | Obstetrician & Gynaecologist
Maternal-Fetal Medicine · Reproductive Endocrinology
Board-certified consultant with 15+ years and 4,000+ major procedures, from emergency obstetrics to advanced gynaecological surgery, now founding medical AI research to reduce mortality in women's and infants' health.
A consultant who treats every high-risk pregnancy as a problem worth solving twice: once at the bedside, and once in the data.
Dr. Oduola-Owoo leads multidisciplinary teams managing complex maternal-fetal and gynaecological cases at a tertiary centre, and heads a Reproductive Endocrinology & Fertility unit where he runs advanced ovulation-induction and fertility protocols. Across 15+ years he has performed over 4,000 major procedures, spanning emergency obstetrics to advanced gynaecological surgery, and read more than 2,000 obstetric scans.
His work extends beyond the operating room into medical innovation. He is the founder of Batlak AI Lab, a medical AI research lab building tools validated for African patients, and serves as Head of the Medical Unit for a Yale-recognised AI health startup. As a site principal investigator on national and international trials, he mentors senior residents and helps shape the evidence base for future standards of care, driven by a single mission: using data-driven innovation to reduce mortality in women's and infants' health.
Directs care for complex and emergency obstetric cases in a tertiary setting, leading expert reviews and morbidity/mortality audits that refine institutional guidelines.
Leads a fertility unit with advanced ovulation-induction protocols, sono-hysterosalpingography, and folliculometry for couples seeking conception.
ISUOG-certified in advanced imaging: dating, anomaly and fetal Doppler scanning, with 2,000+ studies and published Doppler research.
4,000+ major procedures, from myomectomy and hysterectomy to advanced gynaecological oncology and minimal-access laparoscopy and hysteroscopy, plus hands-on surgical training for OBGYN residents.
Directs multidisciplinary teams in high-risk obstetric care, leads the Reproductive Endocrinology & Fertility unit, supervises research for 5+ senior residents, and runs surgical and laparoscopic skills training.
Founded the research arm of Batlak Medical Limited to build AI tools validated for African patients. Provides clinical oversight for FMCEB-CXR, Nigeria's first structured chest X-ray AI benchmark (5,517 studies with paired radiology reports), leads ethics and data governance, and supports a research partnership with the University of Alicante, Spain.
Leads medical strategy for an AI-powered platform recognised in the Yale Africa Startup Review 2025 (#YASR30), building predictive models to flag early preeclampsia and postpartum-haemorrhage risk.
Provides clinical and medical guidance for Triage Home, supporting safe, evidence-based maternal and reproductive-health information for the community it serves.
Implementation Team Lead for the IVON-IS study and coordinator on the PIPSICKLE trial; appointed Focal Doctor for the Sexual & Gender-Based Violence unit, establishing survivor evidence and counselling protocols.
Primary surgeon for complex and referred caesareans and gynaecological surgery; ran high-risk antenatal clinics with a 98% successful-outcome rate in emergency obstetric interventions.
Built a broad surgical and emergency foundation: obstetric and general surgery, neonatal resuscitation, and early adoption of electronic medical records in private practice.
Principal investigator, site investigator and coordinator across national trials targeting the leading causes of maternal mortality in West Africa.
A comprehensive approach to preventing and managing maternal anaemia in Nigeria, designing protocols to cut a leading cause of maternal death.
Site Principal Investigator · 2025 to PresentInvestigating prophylactic IV azithromycin during caesarean section to reduce post-operative sepsis rates.
Site Primary Investigator · 2024 to PresentCoordinated rollout of intravenous iron for moderate-to-severe anaemia, moving beyond oral supplements for faster recovery in high-risk mothers.
Site Coordinator · 2023 to 2024Low-dose aspirin to prevent IUGR and preeclampsia in sickle-cell pregnancy, managing specialised care for pregnant women with sickle-cell disease.
Site Coordinator · 2022 to 2024Evidence for anti-fibrinolytics in preventing primary postpartum haemorrhage during surgery, shaping protocols in tertiary centres.
Principal Investigator · 2021Systematic review synthesising global data on the most effective fertility treatments for ovulation in African women with PCOS.
Co-Investigator · 2024Peer-reviewed publications in international and regional journals, spanning maternal-fetal medicine and diagnostic ultrasound. Each links to the full paper.
Afolabi B.B., Babah O.A., et al. · trial group incl. Oduola-Owoo B.B. (Federal Medical Centre, Ebute-Metta) · multicentre RCT, 476 participants across 16 facilities.
Oduola-Owoo B.B., Olorunfemi G., et al. · anti-fibrinolytic prophylaxis for primary PPH at caesarean section.
Oduola-Owoo L.T., Adeyomoye A.A., Omidiji O.A., Idowu B.M., Oduola-Owoo B.B., Odeniyi I.A. · high-resolution nerve ultrasound for diabetic neuropathy · PMID 38665340.
Oduola-Owoo L.T., Adeyomoye A.A., Olowoyeye O.A., Odeniyi I.A., Idowu B.M., Oduola-Owoo B.B., Aderibigbe A.S. · open access · DOI 10.4103/jwas.jwas_53_22.
Author name appears in the literature as Oduola-Owoo B.B. / Badmus Babatunde Oduola-Owoo · ORCID & Google Scholar links can be added here.
For clinical referrals, trial collaboration, speaking, or advisory work in maternal-fetal medicine and health-tech.
Available for high-risk obstetric consults, fertility care, clinical-trial sites, and AI maternal-health advisory.
Send a message